Skip to main content

Table 2 Baseline laboratory characteristics of patients with COVID-19

From: Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study

VariablesTotal (n = 91)Severe (30, 33.0%)Mild (61, 67.0%)P value
WBC (×10^9/L)0.127
 <427/91 (29.7%)7/30 (23.3%)20/61 (32.8%) 
 4–1053/91 (58.2%)18/30 (60.0%)35/61 (57.4%) 
 >1011/91 (12.1%)5/30 (16.7%)6/61 (9.8%) 
Neutrophil (×10^9/L)0.467
  ≤ 6.380/91 (87.9%)26/30 (86.7%)54/61 (88.5%) 
 >6.311/91 (12.1%)4/30 (13.3%)7/61 (11.5%) 
Monocytes (×10^9/L)0.190
  ≤ 0.666/91 (72.5%)20/30 (66.7%)46/61 (75.4%) 
 >0.625/91 (27.5%)10/30 (33.3%)15/61 (24.6%) 
Lymphocytes (×10^9/L)0.022
  ≤ 1.147/91 (51.6%)11/30 (36.7%)36/61 (59.0%) 
 >1.144/91 (48.4%)19/30 (63.3%)25/61 (41.0%) 
CTnI (μg/L)0.277
  ≤ 0.0185/88 (96.6%)28/30 (93.3%)57/58 (98.3%) 
 >0.013/88 (3.4%)2/30 (6.7%)1/58 (1.7%) 
CK (U/L)0.018
  ≤ 19077/91 (84.6%)22/30 (73.3%)55/61 (90.0%) 
 >19014/91 (15.4%)8/30 (26.7%)6/61 (9.8%) 
CK-MB (U/L)0.099
  ≤ 2487/91 (95.6%)27/30 (90.0%)60/61 (98.4%) 
 >244/91 (4.4%)3/30 (10.0%)1/61 (1.6%) 
ALT (U/L)0.112
  ≤ 5081/91 (89.0%)25/30 (83.3%)56/61 (91.8%) 
 >5010/91 (11.0%)5/30 (16.7%)5/61 (8.2%) 
AST (U/L)0.124
  ≤ 4073/91 (80.0%)22/30 (73.3%)51/61 (83.6%) 
 >4018/91 (19.8%)8/30 (26.7%)10/61 (16.4%) 
Cr (μmol/L)0.000
  ≤ 9786/91 (94.5%)25/30 (83.3%)61/61 (100%) 
 >975/91 (5.5%)5/30 (16.7%)0/61 (0%) 
UA (μmol/L)0.202
  ≤ 41786/91 (94.5%)27/30 (90.0%)59/61 (96.7%) 
 >4175/91 (5.5%)3/30 (10.0%)2/61 (3.3%) 
PT (s)0.100
  ≤ 12.872/91 (79.1%)22/30 (73.3%)50/61 (82%) 
 >12.819/91 (20.9%)8/30 (26.7%)11/61 (18.0%) 
APTT(s)0.202
  ≤ 36.5 s86/91 (94.5%)27/30 (90.0%)59/61 (96.7%) 
 >36.55/91 (5.5%)3/30 (10.0%)2/61 (3.3%) 
D-Dimer (ng/ml)0.484
  ≤ 23278/82 (95.1%)28/30 (93.3%)50/52 (96.2%) 
 >2324/82 (4.9%)2/30 (6.7%)2/52 (3.8%) 
IL-6 (ng/ml)0.485
  ≤ 773/91 (80.2%)24/30 (80.0%)49/61 (80.3%) 
 >718/91 (19.8%)6/30 (20.0%)12/61 (19.7%) 
CRP (mg/ml)0.240
  ≤ 1056/91 (61.5%)20/30 (66.7%)36/61 (59.0%) 
 >1035/91 (38.5%)10/30 (33.3%)25/61 (41.0%) 
PCT (ng/ml)0.106
  ≤ 0.585/89 (95.5%)27/30 (90.0%)58/59 (98.3%) 
 >0.54/89 (4.5%)3/30 (10.0%)1/59 (1.7%) 
  1. Data are n/N (%), where N is the total number of patients with available data. p values comparing severe and mild groups used Chi-square test, Chi-square with Yates’ correction, or Fisher’s exact test
  2. WBC White blood cell, CTnI Cardiac troponin I, CK Creatine kinase, CK-MB Creatine kinase isoenzyme, ALT Alanine aminotransferase, AST Aspartate aminotransferase, Cr Creatinine, UA Uric acid, PT Prothrombin time, APTT Activated partial thromboplastin time, IL-6 Interleukin 6, CRP C-reactive protein, PCT Procalcitonin